A man’s cancer vanished after he was injected with a weakened herpes virus in a promising clinical trial
He was preparing for the end of his life when he learned about the experimental drug
New trial finds first-ever Alzheimer’s drug to slow cognitive decline
A Phase 3 trial testing lecanemab recruited just under 2,000 participants in the early stages of Alzheimer’s disease
COVID raises risk of long-term brain injury, large US study finds
The year-long study, published in Nature Medicine, assessed brain health across 44 different disorders